Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 33.35
-0.20 (-0.60%)
At close: Dec 5, 2025
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 4.16 billion as of December 5, 2025. Its market cap has decreased by -51.25% in one year.
Market Cap
4.16B
Enterprise Value
4.18B
Revenue
588.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.35
Market Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 4.16B, an increase of 829.46%. That is a compound annual growth rate of 12.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.16B | -46.93% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | 2.42B | 94.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.69B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 34.78B |
| Lumosa Therapeutics | 32.51B |
| Center Laboratories | 27.88B |